Yayın:
Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?

dc.contributor.buuauthorGüneş, Muhammed
dc.contributor.buuauthorÇekiç, Şükrü
dc.contributor.buuauthorKılıç, Sara Şebnem
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPediatrik İmmünoloji Romatoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-9574-1842
dc.contributor.orcid0000-0001-8571-2581
dc.contributor.researcheridL-1933-2017
dc.contributor.researcheridAAH-1658-2021
dc.contributor.scopusid57194145381
dc.contributor.scopusid56117061000
dc.contributor.scopusid34975059200
dc.date.accessioned2022-12-26T10:56:58Z
dc.date.available2022-12-26T10:56:58Z
dc.date.issued2017-06
dc.description.abstractBackgroundPeriodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome is the most frequent repetitive fever syndrome in childhood. It is characterized by fever episodes lasting for approximately 3-6 days, once every 3-8 weeks. MethodsClinical and laboratory data for PFAPA syndrome patients between January 2010 and December 2014 followed up at a tertiary pediatric care hospital were reviewed. ResultsFour hundred children (256 male, 144 female; mean age at diagnosis, 4.2 2.2 years), were enrolled in the study. During the episodes, mean leukocyte number was high (12 725/mm(3)) with predominant neutrophils. The mean number of monocytes was 1256/mm(3), and 90.2% had monocytosis. Serum amyloid A and C-reactive protein were high in 84.6% and in 77.8% of the patients, respectively. Mediterranean fever (MEFV) gene heterozygous mutation was identified in 57 of the 231 patients (24.7%) in whom genetic analysis had been performed. The most frequent mutation was heterozygous M694V (10%, n = 23). Extension of between-episode interval following prophylaxis was noted in 85% of those on regular colchicine treatment (n = 303). In the colchicine group, between-episode interval was prolonged from 18.8 +/- 7.9 days (before colchicine treatment) to 49.5 +/- 17.6 days on prophylactic colchicine therapy; also, prophylactic treatment was more effective in reducing episode frequency in patients with MEFV gene variant (n = 54, 96%) than in those without (n = 122, 80%; P = 0.003). ConclusionsThis study has involved the largest number of PFAPA syndrome patients in the literature. It is particularly important to assess and to demonstrate the high rate of response to colchicine prophylaxis in PFAPA syndrome patients, especially those with MEFV variant. On blood screening, neutrophilia associated with monocytosis and low procalcitonin could contribute to diagnosis.
dc.identifier.citationGüneş, M. vd. (2017). ''Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?''. Pediatrics International, 59(6), 655-660.
dc.identifier.doi10.1111/ped.13265
dc.identifier.endpage660
dc.identifier.issn1328-8067
dc.identifier.issue6
dc.identifier.pubmed28207965
dc.identifier.scopus2-s2.0-85018861476
dc.identifier.startpage655
dc.identifier.urihttps://doi.org/10.1111/ped.13265
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/ped.13265
dc.identifier.uri1442-200X
dc.identifier.urihttp://hdl.handle.net/11452/30086
dc.identifier.volume59
dc.identifier.wos000403725600001
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.journalPediatrics International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPediatrics
dc.subjectChild
dc.subjectColchicine
dc.subjectMEFV
dc.subjectPeriodic fever
dc.subjectPFAPA syndrome
dc.subjectClinical characteristics
dc.subjectPfapa syndrome
dc.subjectMutations
dc.subjectFMF
dc.subject.emtreeAmyloid A protein
dc.subject.emtreeC reactive protein
dc.subject.emtreeColchicine
dc.subject.emtreeFibrinogen
dc.subject.emtreePrednisolone
dc.subject.emtreeProcalcitonin
dc.subject.emtreeColchicine
dc.subject.emtreeMEFV protein, human
dc.subject.emtreePyrin
dc.subject.emtreeTubulin modulator
dc.subject.emtreeArticle
dc.subject.emtreeChild
dc.subject.emtreeCohort analysis
dc.subject.emtreeControlled study
dc.subject.emtreeDiarrhea
dc.subject.emtreeDisease association
dc.subject.emtreeDisease severity
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug response
dc.subject.emtreeDrug safety
dc.subject.emtreeErythrocyte sedimentation rate
dc.subject.emtreeFamilial Mediterranean fever
dc.subject.emtreeFemale
dc.subject.emtreeFibrinogen blood level
dc.subject.emtreeFollow up
dc.subject.emtreeGene
dc.subject.emtreeGene mutation
dc.subject.emtreeGenetic analysis
dc.subject.emtreeGenetic association
dc.subject.emtreeGenetic variability
dc.subject.emtreeHeterozygosity
dc.subject.emtreeHuman
dc.subject.emtreeInfant
dc.subject.emtreeLeukocyte count
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMEFV gene
dc.subject.emtreeMonocyte
dc.subject.emtreeMonocytosis
dc.subject.emtreeNeutrophil count
dc.subject.emtreePFAPA syndrome
dc.subject.emtreePriority journal
dc.subject.emtreeProphylaxis
dc.subject.emtreeProtein blood level
dc.subject.emtreeTreatment duration
dc.subject.emtreeAphthous stomatitis
dc.subject.emtreeDrug administration
dc.subject.emtreeFamilial Mediterranean fever
dc.subject.emtreeFever
dc.subject.emtreeGenetic marker
dc.subject.emtreeGenetics
dc.subject.emtreeLymphadenitis
dc.subject.emtreeMutation
dc.subject.emtreeNeck
dc.subject.emtreePharyngitis
dc.subject.emtreePreschool child
dc.subject.emtreeRetrospective study
dc.subject.emtreeSyndrome
dc.subject.emtreeTreatment outcome
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshColchicine
dc.subject.meshDrug administration schedule
dc.subject.meshFamilial mediterranean fever
dc.subject.meshFemale
dc.subject.meshFever
dc.subject.meshFollow-up studies
dc.subject.meshGenetic markers
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshLymphadenitis
dc.subject.meshMale
dc.subject.meshMutation
dc.subject.meshNeck
dc.subject.meshPharyngitis
dc.subject.meshPyrin
dc.subject.meshRetrospective studies
dc.subject.meshStomatitis, aphthous
dc.subject.meshSyndrome
dc.subject.meshTreatment outcome
dc.subject.meshTubulin modulators
dc.subject.scopusAphthous Stomatitis; Lymphadenitis; PFAPA Syndrome
dc.subject.wosPediatrics
dc.titleIs colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Pediatrik İmmünoloji Romatoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Güneş_vd_2017.pdf
Boyut:
126.81 KB
Format:
Adobe Portable Document Format
Açıklama

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama